Kathleen M. Sakamoto

Kathleen M. Sakamoto

Professional Education

  • Board Certification: Pediatric Hematology-Oncology, American Board of Pediatrics (1992)
  • Board Certification: Pediatrics, American Board of Pediatrics (1989)
  • Ph.D., California Institute of Technology, Biology (2004)
  • Residency: Children's Hospital Los Angeles (1988) CA
  • Fellowship: Children's Hospital Los Angeles (1991) CA
  • Fellowship, Children's Hospital Los Angeles, Pediatric Hematology/Oncology (1991)
  • Internship and Residency, Children's Hospital Los Angeles, Pediatrics (1988)
  • Postdoctoral Fellowship, UCLA School of Medicine, Hematopoietic growth factors and signal transduction (1992)
  • Medical Education: University of Cincinnati College of Medicine (1985) OH
  • M.D., University of Cincinnati College of Medicine, Medicine (1985)
  • B.A., Williams College, Biology (1979)

Honors & Awards

  • Brett Ely Visiting Professor in Pediatric Oncology, University of Colorado and Children's Hospital Denver (2011)
  • Chair, Myeloid Biology Subcommittee, American Society of Hematology (2011)
  • Fernbach Distinguished Visiting Professor Lectureship, Texas Children's Cancer Center (2009)
  • Gift of Hope Award, Pediatric Cancer Research Foundation (2008)
  • Junior Faculty Ross Research Award, Western Society for Pediatric Research (1996)
  • Outstanding advances in cancer research award, Mendiburu Magic Foundation (2010)
  • Standing Member, NIDDK-D Study Section for Training Grants and K awards (2011-present)
  • STOP Cancer Career Development award, UCLA Jonsson Comprehensive Cancer Center (1992)
  • Victor E. Stork Award, Children's Hospital of Los Angeles (1988)
  • Young Investigator Award, American Society of Pediatric Hematology/Oncology (1994)

Administrative Appointments

  • Chief, Division of Pediatric Hematology/Oncology/Stem Cell Transplantation/Cancer Biology, Bass Cancer Center, Lucile Packard Children's Hospital (2011 - 2014)
  • Fellowship Program Director, Division of Pediatric Hematology-Oncology, Stanford University School of Medicine (2011 - 2013)

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.